The present invention aims to provide a sweetness receptor antagonist useful for the prophylaxis or treatment of metabolic syndrome, diabetes, obesity and the like. A sweetness receptor antagonist containing a compound represented by the formula (I)
wherein each symbol is as described in the DESCRIPTION, or a salt thereof.
申请人:THE NUTRASWEET COMPANY
(a Delaware corporation)
公开号:EP0299533B1
公开(公告)日:1993-04-07
NOFRE, CLAUDE;TINTI, JEAN MARIE;OUAR, FARROUDJA
作者:NOFRE, CLAUDE、TINTI, JEAN MARIE、OUAR, FARROUDJA
DOI:——
日期:——
US9907766B2
申请人:——
公开号:US9907766B2
公开(公告)日:2018-03-06
Use of Molecular Oxygen as a Reoxidant in the Synthesis of 2-Substituted Benzothiazoles via Palladium-Catalyzed CH Functionalization/Intramolecular CS Bond Formation
作者:Kiyofumi Inamoto、Chisa Hasegawa、Junpei Kawasaki、Kou Hiroya、Takayuki Doi
DOI:10.1002/adsc.201000604
日期:2010.10.4
Molecularoxygen (O2) was successfully employed as a reoxidant in cyclizations of thiobenzanilides 1a–s through a palladium-catalyzed CH functionalization/intramolecular CS bondformation process, leading to an efficient, green method for the synthesis of 2-arylbenzothiazoles 2a–s. Addition of cesium fluoride (CsF) greatly enhanced the reactions, which produced variously substituted 2-arylbenzothiazoles